Bond managers add their voice to the ESG effort

Boom in advocates of ethical investment

clock
Hannah Strasser of SKY Harbor Capital Management
Image:

Hannah Strasser of SKY Harbor Capital Management

There is a virtuous cycle to fixed income high-yield investing, and one that can be more meaningful when ESG is integrated into the investment process, writes Hannah Strasser, co-founder and managing director of SKY Harbor Capital Management.

Companies that implement long-term strategies to withstand pressures of changing demographics, market preferences and environmental conditions are ultimately those best positioned to manage financial risks and reduce their cost of capital. The virtuous part of the cycle is that companies that benefit from this type of investment approach are those that are actively reducing negative externalities associated with their operations, and are aiming to have an increasingly positive impact on society. BlackRock launches ESG range of EMD funds Identifying companies that have both good fin...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Industry Voice: Multi-asset managers highlight diversifiers for troubled times

Industry Voice: Multi-asset managers highlight diversifiers for troubled times

Katrina Lloyd @ Investment Week
clock 17 August 2022 • 6 min read
Partner insight: Out of the wilderness

Partner insight: Out of the wilderness

Solving the problem of inertia in cash gives opportunities to both advisers and their clients, say Flagstone's Claire Jones and Grovewood Wealth Management's Lynne Gadsden.

Lynne Gadsden @ Flagstone
clock 11 August 2022 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot